1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is €6.77 (+15.33%). The median is €6.48 (+10.39%).
| Buy |
4 |
| Hold |
3 |
| Sell |
4 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 17.66M | 58.04% |
| Gross profit | 16.15M | 45.26% |
| Net profit | -40.93M | 20.00% |
| EBITDA | -38.87M | 0.58% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €392.72M |
Number of shares | 65.32M |
52-week high/low | €15.18 - €4.64 |
| Dividends | No |
Beta | 1.79 |
P/E ratio | -1.39 |
PEG ratio | -0.09 |
P/B ratio | 1.03 |
P/S ratio | 4.06 |
Company profile
| Name | Ginkgo Bioworks Holdings A Aktie |
| CEO | Jason Kelly |
| Employees | 485 |
Deep Dive
Discover assets
Shareholders of Ginkgo Bioworks Holdings A Aktie also invest in the following assets
